Shares of LivaNova PLC (NASDAQ:LIVN) shot up 3% during mid-day trading on Friday . The company traded as high as $62.59 and last traded at $62.56, with a volume of 300,797 shares. The stock had previously closed at $60.71.

Separately, Piper Jaffray Cos. restated an “overweight” rating and set a $70.00 target price (up previously from $59.00) on shares of LivaNova PLC in a research note on Friday, August 5th. Five research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $69.00.

The firm has a 50 day moving average of $52.72 and a 200 day moving average of $53.01. The firm’s market capitalization is $3.07 billion.

In other LivaNova PLC news, insider Jacques Gutedel sold 4,000 shares of the company’s stock in a transaction on Tuesday, August 9th. The shares were sold at an average price of $60.52, for a total transaction of $242,080.00. Following the transaction, the insider now owns 10,948 shares in the company, valued at $662,572.96. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction on Tuesday, May 24th. The stock was sold at an average price of $50.07, for a total transaction of $50,070.00. Following the transaction, the director now owns 64,137 shares in the company, valued at approximately $3,211,339.59. The disclosure for this sale can be found here.

Several hedge funds have recently bought and sold shares of the company. First Trust Advisors LP purchased a new stake in LivaNova PLC during the fourth quarter valued at about $1,134,000. Platinum Investment Management Ltd. purchased a new stake in LivaNova PLC during the fourth quarter valued at about $1,423,000. Comerica Bank purchased a new stake in LivaNova PLC during the fourth quarter valued at about $1,542,000. New York State Common Retirement Fund purchased a new stake in LivaNova PLC during the fourth quarter valued at about $2,404,000. Finally, Calvert Investment Management Inc. purchased a new stake in LivaNova PLC during the fourth quarter valued at about $4,025,000.

LivaNova PLC is a United Kingdom-based medical technology company. The Company focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company operates under three business units: Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. The Company provides solutions for patients, healthcare professionals and healthcare systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.